Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 12
Summary
- Conditions
- Brain Metastases
- Metastatic Breast Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03807765
- Collaborators
- Bristol-Myers Squibb
- Investigators
- Principal Investigator: Kamran Ahmed, MD H. Lee Moffitt Cancer Center and Research Institute
Get Well Soon